Abstract Details

Title Mutations in ERBB4 That Disrupt The NRG-ErbB4 Pathway Cause Autosomal Dominant Familial ALS Type 19

Topic Neuromuscular and Clinical Neurophysiology (EMG)

Presentation(s) (-)

Poster/Presentation
Number 083

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Hiroyoko Moritoyo, MD (Musashimurayama Hospital)	No disclosure on file
	No disclosure on file
	No disclosure on file
Guy A. Rouleau, MD, PhD, F�鶹��ýӳ�� (Montreal Neurological Institute and Hospital)	Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.
	No disclosure on file
	No disclosure on file
Jun Goto, MD, PhD (International University of Health and Welfare Ichikawa Hospital)	No disclosure on file
Shoji Tsuji, MD, PhD (University of Tokyo)	The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..